Laman Utama500257 • BOM
add
Lupin Ltd
Tutup sebelumnya
₹2,006.30
Julat hari
₹1,987.50 - ₹2,020.80
Julat tahun
₹1,200.35 - ₹2,312.00
Permodalan pasaran
958.92B INR
Bilangan Purata
27.12K
Nisbah P/E
34.83
Hasil dividen
0.40%
Pertukaran utama
NSE
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (INR) | Sep 2024info | Perubahan T/T |
|---|---|---|
Hasil | 56.73B | 12.59% |
Perbelanjaan pengendalian | 28.73B | 7.98% |
Pendapatan bersih | 8.53B | 74.12% |
Margin untung bersih | 15.03 | 54.63% |
Pendapatan bagi setiap syer | 18.64 | 73.88% |
EBITDA | 13.62B | 48.62% |
Kadar cukai berkesan | 18.52% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (INR) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 29.12B | 68.06% |
Jumlah aset | 254.82B | 8.69% |
Jumlah liabiliti | 97.62B | -3.69% |
Jumlah ekuiti | 157.20B | — |
Syer tertunggak | 455.95J | — |
Harga kepada buku | 5.85 | — |
Pulangan pada aset | — | — |
Pulangan pada modal | 15.22% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (INR) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 8.53B | 74.12% |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. The company's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis. Wikipedia
Diasaskan
1968
Ibu pejabat
Tapak web
Pekerja
19,210
